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Summary Statement 17 
 18 
The histone demethylase Lsd1 is required for inner ear progenitor specification and acts in a 19 
complex with the Myb transcription factor. Myb recruits Lsd1 to the promoter of key otic 20 
determinants, where it controls H3K9 demethylation to maintain their active transcription.  21 
3 
 
Abstract 22 
 23 
During development, multipotent progenitor cells must maintain their identity while retaining 24 
the competence to respond to new signalling cues that drive cell fate decisions. This 25 
depends on both DNA-bound transcription factors and surrounding histone modifications. 26 
Here we identify the histone demethylase Lsd1 as a crucial component of the molecular 27 
machinery that preserves progenitor identity in the developing ear prior to lineage 28 
commitment. While Lsd1 is mainly associated with repressive complexes, we show that in 29 
ear precursors it is required to maintain active transcription of otic genes. We reveal a novel 30 
interaction between Lsd1 and the transcription factor cMyb, which in turn recruits Lsd1 to the 31 
promoters of key ear transcription factors. Here, Lsd1 prevents the accumulation of 32 
repressive H3K9me2 while allowing H3K9 acetylation. Loss of Lsd1 function causes rapid 33 
silencing of active promoters, loss of ear progenitor genes and shuts down the entire ear 34 
developmental programme. Our data suggest that Lsd1-cMyb acts as a coactivator complex 35 
that maintains a regulatory module at the top of the inner ear gene network.  36 
4 
 
Introduction 37 
 38 
In the developing embryo, multipotent progenitors are able to maintain their identity and 39 
gene expression programmes despite ongoing changes in their signalling environment. We 40 
have recently uncovered a gene network that integrates signalling inputs and transcriptional 41 
activity during the transition from progenitor to committed inner ear cells (Anwar et al, 2017; 42 
Chen et al, 2017), providing a good basis to explore this problem in a well-defined system. 43 
The entire inner ear is derived from a simple epithelium, the otic placode, located in the 44 
ectoderm next to the hindbrain. Prior to placode formation, otic precursors are part of a 45 
sensory progenitor pool (the pre-placodal region, PPR), from which FGF signalling induces 46 
otic-epibranchial progenitors (OEPs) (Anwar et al, 2017; Ladher et al, 2000; Maroon et al, 47 
2002; Martin & Groves, 2006; Sun et al, 2007; Urness et al, 2010; Wright & Mansour, 2003). 48 
Over time, OEPs segregate into committed ear and epibranchial cells. They do this gradually 49 
by responding to new signalling cues and by altering their transcriptional machinery (Chen et 50 
al, 2017; Freter et al, 2008; Jayasena et al, 2008; Park & Saint-Jeannet, 2008; Sun et al, 51 
2007). Thus, during this transitional period OEPs must maintain their identity before 52 
proceeding to lineage commitment. The molecular mechanisms that maintain the 53 
competence of OEPs to respond to signals and maintain their progenitor state have not been 54 
identified. 55 
Epigenetic mechanisms such as histone modifications are known to maintain 56 
progenitor cell identity as well as prime them for differentiation (Martin & Zhang, 2005), and 57 
may therefore play a role in keeping cells in an OEP state. One such modification is histone 58 
methylation in gene bodies and regulatory regions (Layman & Zuo, 2014; Ooi & Wood, 59 
2007) associated with either gene activation or repression. In placode-derived sense organs, 60 
virtually nothing is known about the epigenetic control of cell identity as cells transit from 61 
progenitor to lineage commitment. The histone demethylase Kdm4b (also known as 62 
JmjD2B), which specifically removes di- and trimethyl groups from lysine 9 of histone 3 63 
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(H3K9me2/3) (Labbé et al, 2014), is the only epigenetic enzyme identified in inner ear 64 
precursors to date and controls placode invagination at later stages (Uribe et al, 2015). 65 
Recent RNAseq analysis (Chen et al, 2017) identified the demethylase Lsd1 as specifically 66 
enriched in OEPs, suggesting that it could be involved in ear specification. 67 
Lsd1 plays a key role in maintaining the pluripotency of stem cells (Adamo et al, 68 
2011), as well as acting as a molecular toggle switch that promotes or inhibits differentiation 69 
of progenitor cells (Laurent et al, 2015). Lsd1 (also known as Kdm1a/Aof2/BHC110) is a 70 
flavin-dependent demethylase that specifically removes active H3K4me1/2 or repressive 71 
H3K9me1/2 marks, and thus can function as a transcriptional repressor or activator (Forneris 72 
et al, 2006; Metzger et al, 2016; Metzger et al, 2005). Consistent with this, it is found in both 73 
corepressor and coactivator complexes such as REST-CoREST (Ballas et al, 2005; Lee et 74 
al, 2005; Shi et al, 2005) and androgen receptor (AR)-Chd1 complexes (Metzger et al, 2016; 75 
Metzger et al, 2005). Here, we show that Lsd1 is indispensable for ear development. It is 76 
required to maintain the expression of key progenitor-specific genes (Sox8, Pax2, Etv4 and 77 
Zbtb16) that feed into a larger gene regulatory network that controls ear commitment. We 78 
identify cMyb as a novel Lsd1 interacting partner that recruits Lsd1 to promoter regions of 79 
actively transcribed genes to maintain the active histone mark H3K9ac by catalysing H3K9 80 
demethylation.  81 
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Results 82 
 83 
Lsd1 is expressed in OEPs after their specification 84 
The commitment of OEPs towards an otic fate is a gradual process that requires the 85 
integration and fine-tuning of gene regulatory networks (Chen et al, 2017). OEP specification 86 
by FGF signals begins around somite stage (ss) 1 in chick embryos (Groves & Bronner-87 
Fraser, 2000). By ss5 OEPs express high levels of the FGF mediators Etv4 and Etv5 (Anwar 88 
et al, 2017; Betancur et al, 2011; Lunn et al, 2007) and develop along the otic lineage when 89 
cultured in isolation (Groves & Bronner-Fraser, 2000). However, it is not until ss10 that the 90 
otic lineage becomes molecularly distinct from the epibranchial cells (Chen et al, 2017), 91 
becoming fully committed to otic fate by ss11-12 (Groves & Bronner-Fraser, 2000). This 92 
progressive commitment is driven by a sequential activation of different signalling pathways 93 
(Freter et al, 2008; Jayasena et al, 2008; Park & Saint-Jeannet, 2008; Shida et al, 2015). 94 
The mechanisms whereby OEPs maintain their identity and remain poised for rapid 95 
response to new signals have not been identified. 96 
We hypothesised that epigenetic mechanisms may be involved, and using our recent 97 
RNA-seq data (Chen et al, 2017), we identified Lsd1 as a candidate for maintaining OEP 98 
identity prior to lineage commitment. Lsd1 is expressed immediately after OEP specification 99 
but prior to molecular segregation of the otic-epibranchial lineages. We confirmed this by in 100 
situ hybridisation. At ss5, Lsd1 is confined to the neural tube, with weak expression in the 101 
mesoderm, but absent from OEPs (Fig.1A, a). At ss8, it becomes expressed in OEPs 102 
(Fig.1B, b), and by ss13, it is robustly expressed in the otic placode and weakly in more 103 
lateral ectoderm (Fig.1C, c). To determine the onset of Lsd1 expression, we performed 104 
qPCR from dissected OEPs and placodes, and compared its expression to that of the 105 
transcription factor Pax2, an established, FGF-responsive OEP marker (Chen et al, 2017; 106 
Nechiporuk et al, 2007; Phillips et al, 2001; Yang et al, 2013). This analysis confirms the 107 
absence of Lsd1 from OEPs at ss5 and its upregulation at ss8 (Fig.1D), preceding the 108 
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segregation of otic and epibranchial lineages. Thus, Lsd1 expression is activated in OEPs 109 
after they have been specified, and its expression persists as otic cells become committed. 110 
 111 
Lsd1 is necessary for otic placode formation and subsequent differentiation 112 
To test directly if Lsd1 is required to maintain OEP identity, we performed knock-down 113 
experiments using two different morpholinos (MO) against Lsd1 (Lsd1-MO; both affect Lsd1 114 
splicing; Fig.S1A). We find that Lsd1 knock-down with either MO leads to a dramatic 115 
reduction of otic vesicle size as compared to the control side (n=16, Fig.2A-b’) indicating an 116 
important role for Lsd1 in ear development. 117 
To understand global changes in the otic gene network after Lsd1 knockdown, we 118 
designed a NanoString probeset containing 220 transcripts based on our RNAseq data 119 
(Chen et al, 2017), which includes 70 otic genes as well as factors specific for other 120 
placodes, neural, epidermal and neural crest cells (TableS1). Lsd1-MOs were electroporated 121 
into OEPs at ss5-6, and otic tissue was analysed after 4.5 and 9 hours corresponding to ss8-122 
9 and ss11-12, respectively. Experiments were performed in triplicate and genes with a fold 123 
change ≥+/-1.5 and a p-value ≤0.05 were considered to be deregulated (TableS2). 124 
Several genes are rapidly upregulated after Lsd1 knockdown. These include the 125 
Notch targets Hes4 and Hey1 (a direct negatively-regulated Lsd1 target (Wang et al, 2007), 126 
the Notch ligand Jag1 and Cbx4, a component of the Lsd1-CtBP and the PRC2 corepressor 127 
complexes (Shi et al, 2003; Tsai et al, 2010; Wang et al, 2007) (Fig.3A).This is followed by 128 
increase of a number of lineage markers: the epidermal marker Gata2 (Sheng & Stern, 129 
1999), the neural crest genes Snail1, Msx1 and Id4 (Kee & Bronner-Fraser, 2001; Nieto, 130 
2002; Streit, 2002), and the lens-specific transcripts Pax6, Zeb2, L-Maf and C-Maf (Bailey et 131 
al, 2006; Bhattacharyya et al, 2004; Lecoin et al, 2004; Sheng et al, 2003) (Fig.3B). These 132 
data suggest that Lsd1 normally represses these transcripts and may prevent the switch of 133 
OEPs to other fates. By contrast, Lsd1 knockdown leads to loss of either OEP-specific 134 
genes (e.g. Sox8, Pax2, Zbtb16, Etv4) or genes that are already expressed at PPR stages 135 
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(e.g. Foxi3, Gbx2, Spry1/2, Six1, Eya2, Znf385c) with Sox8, Pax2 and Spry2 showing the 136 
greatest fold change (Fig.3A). Most of these genes are dependent on FGF signalling (Chen 137 
et al, 2017; Yang et al, 2013), and continue to be downregulated 9 hours after Lsd1 knock 138 
down, when additional downstream genes such as Sox10 (a target of both Sox8 and Etv4) 139 
(Betancur et al, 2011) are also reduced. These data indicate that Lsd1 is critically required to 140 
maintain the transcriptional profile of OEPs, while simultaneously preventing alternative 141 
fates. 142 
To validate the NanoString data and as an alternative approach to perturb Lsd1 143 
function, we cultured OEP explants in the presence of tranylcypromine (TCP) – a well-144 
documented Lsd1 inhibitor (Schmidt and McCafferty, 2007) – and then performed qPCR for 145 
selected genes. This approach verifies the downregulation of OEP and posterior PPR genes 146 
at ss8-9 (Fig.3C, Sox8, Pax2, Etv4, Zbtb16, Foxi3, Znf385c) but not the upregulation of other 147 
genes (Fig.S1B). There is no increase in activated Caspase 3 in Lsd1-MO targeted OEPs 148 
(Fig.S4), indicating that reduction of Lsd1 does not promote apoptosis but that instead, 149 
OEPs lose their identity. Analysing OEP markers by in situ hybridisation 9-12 hours post MO 150 
electroporation reveals a complete loss of Pax2 (n=8, Fig.2C-c), Zbtb16 (n=6, Fig.2D-d) and 151 
Etv4 (n=6, Fig.2E-e) after Lsd1 knockdown, while upregulated genes cannot be verified 152 
(Fig.S1C, C’). Interestingly, although Lsd1-MO only target the ectodermal layer, Etv4 153 
expression is also affected in the underlying mesoderm and endoderm, pointing to reciprocal 154 
signalling between these layers and the placode. The epibranchial expression of Pax2 is 155 
also abolished (Fig.2c), and other epibranchial markers like Foxi2 are reduced (n=5, 156 
Fig.S2D-d”). Morphologically, the placode is thinner, having lost the characteristic epithelial 157 
thickening compared to the control side (Fig.2c-e; inset in Fig2c; Fig.S3I-L). Only cells that 158 
escape being targeted by Lsd1-MO maintain Pax2 expression and coalesce to form a 159 
hypoplastic cup or vesicle (n=8, Fig.S2A-a; Fig.S3E-H), whereas control morpholinos (Ctrl-160 
MO) do not affect normal placode involution into a cup (n=6, Fig.S2B, B’) or vesicle (n=4, 161 
Fig.S2C, C’). Pax2 expression, loss of epithelial thickening as well as the late morphological 162 
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phenotype can be rescued by co-electroporating Lsd1-MO with full length human Lsd1-RFP 163 
(Fig.S3). Together, these data strongly support a role for Lsd1 in maintenance of the OEP 164 
transcriptional state and suggest that in this context it may act as a coactivator of OEP 165 
genes that determine OEP fate. 166 
 167 
Lsd1 changes H3K9 modifications at OEP gene promoters 168 
If Lsd1 functions as a direct coactivator of OEP and PPR genes, it should associate with 169 
their promoter regions to modify histone tails. To investigate this, we performed Lsd1 ChIP-170 
qPCR on otic placodes and found that the promoters of Sox8, Pax2, Etv4 and Zbtb16 were 171 
bound by Lsd1, while promoters of Spry2, Foxi3, Six1 and Znf385c did not show any 172 
significant Lsd1 recruitment (Fig.4A, Fig.S5). Thus, OEP genes are direct Lsd1 targets, while 173 
PPR factors are likely to be regulated indirectly. 174 
As a coactivator, Lsd1 acts by demethylating the repressive H3K9me2 found 175 
predominantly at silent promoters (Barski et al, 2007). H3K9 has a dual function at gene 176 
promoters, with opposing roles depending on its modification: acetylation is associated with 177 
gene activation, whereas methylation rapidly silences gene expression (Karmodiya et al, 178 
2012). Thus, H3K9me2 demethylation by Lsd1 (Metzger et al, 2016; Metzger et al, 2005) 179 
allows H3K9 acetylation, thereby maintaining an open chromatin state, while H3K9me2 180 
accumulation in the absence of Lsd1 prevents H3K9ac and the chromatin remains closed 181 
(Fig.4B). Indeed, when Lsd1 is knocked down using MOs or inhibited by TCP, H3K9me2 182 
increases in otic placode cells (Fig.S6). Importantly, using ChIP-qPCR for H3K9me2 and 183 
H3K9ac, we find that Lsd1 inhibition in OEP explant cultures by TCP results in an increase in 184 
H3K9me2 (Fig.4C) and a corresponding decrease in H3K9ac (Fig.4D) at the promoters of 185 
Sox8, Pax2, Etv4 and Zbtb16. These data suggest that Lsd1 is normally recruited to the 186 
promoters of active OEP genes to prevent the accumulation of H3K9me2 and the loss of 187 
H3K9ac, thus allowing their continued expression. 188 
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 189 
cMyb interacts with Lsd1 and recruits it to target promoters 190 
Lsd1 itself lacks the ability to bind DNA or to recognise the H3 tail within nucleosomes (Shi et 191 
al, 2005). How is Lsd1 recruited specifically to the promoters of OEP genes? As a 192 
corepressor, Lsd1 interacts with the cofactor of REST (CoREST) via its chromatin-interacting 193 
SANT2 domain (Ballas et al, 2005; Lee et al, 2005; Shi et al, 2005), or with SNAG-domain 194 
transcription factors (such as Snail1/2 and Gfi1) (Lin et al, 2010; Saleque et al, 2007), which 195 
recruit Lsd1 to their respective target genes. To investigate which factor is responsible for 196 
recruiting Lsd1 to the promoters of Sox8, Pax2, Etv4 and Zbtb16, we performed a motif 197 
enrichment analysis on these promoters using RSAT (Fig.5A; TableS3). To narrow down 198 
potential Lsd1 partners in the ear, we removed factors belonging to the general 199 
transcriptional machinery and factors that are not expressed in OEPs. This strategy 200 
eliminates SNAG domain factors and hormone nuclear receptors, while returning Sox8, 201 
Pax2 as well as the SANT-domain containing coREST (via the presence of REST motif) and 202 
Myb as highly enriched motifs. Of those, Myb emerges as the top candidate to recruit Lsd1 203 
to OEP gene promoters. Myb motifs are enriched in all four promoters (Fig.5A), cMyb is 204 
expressed specifically in OEPs at ss5-6, just prior to Lsd1 (Betancur et al, 2011), it contains 205 
a SANT domain, and together with its transactivation domain, it can function as a coactivator 206 
or a corepressor (Boyer et al, 2004). Morpholino-mediated knockdown of cMyb in OEPs at 207 
ss3-4 leads to the loss of Lsd1-targets like Pax2 (n=6, Fig.S7A-b) and Zbtb16 (n=5, Fig.S7B, 208 
B’), but not of Lsd1 expression (Fig.S7C-J). 209 
To assess whether cMyb and Lsd1 physically interact, we used lysates from 210 
neuroblastoma cells which express these proteins in abundance (Fig.5B) to perform co-211 
immunoprecipitation. While cMyb antibodies do not work in immunoprecipitation, Lsd1 212 
antibodies successfully precipitate Lsd1 protein (Fig. 5B’’). We therefore used Lsd1 antibody 213 
for immunoprecipitation followed by western blotting with cMyb antibody; this reveals that 214 
both proteins interact (Fig.5B’). We then asked whether cMyb is required for Lsd1 binding to 215 
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the Sox8, Pax2, Etv4 and Zbtb16 promoters. Control or cMyb-MOs (Betancur et al, 2011) 216 
were electroporated into OEPs at ss3, targeted cells were harvested 10.5 hours later at ss10 217 
and processed for Lsd1 ChIP followed by qPCR for Sox8, Pax2, Etv4 and Zbtb16 promoter 218 
regions. While Lsd1 binds all four promoters in controls, this is strongly reduced when cMyb 219 
is knocked down (Fig.5C). Together, our data suggest that cMyb and Lsd1 proteins 220 
physically interact and that cMyb recruits Lsd1 to the promoters of the OEP genes Sox8, 221 
Pax2, Etv4 and Zbtb16. In turn, this keeps H3K9 demethylated and allows its acetylation 222 
thus maintaining OEP gene expression.  223 
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Discussion 224 
 225 
While the epigenetic mechanisms that maintain stem cell pluripotency and the exit from this 226 
state in vitro are fairly well characterised, their role in controlling cell fate decisions and 227 
maintaining cell identity in normal embryonic development is much less understood. Here we 228 
take advantage of the recently established gene regulatory network for ear development to 229 
investigate the epigenetic mechanisms that maintain ear precursors in a progenitor state 230 
prior to lineage commitment. Ear commitment is a gradual process that begins with OEP 231 
specification from a pool of sensory progenitors. Exposed to a changing extrinsic 232 
environment as morphogenesis proceeds, OEPs must stabilise their identity and retain 233 
competence to respond to signals that ultimately commit them to their fate (Fig.6A). Here, 234 
we establish a central role for the demethylase Lsd1 in this process, driven by the 235 
transcription factor cMyb (Fig.6B,C). 236 
 237 
Lsd1 maintains the OEP module at the top of the inner ear regulatory network 238 
The control of OEP specification and their subsequent commitment to either the otic or 239 
epibranchial lineages involves a hierarchical organisation of gene regulatory networks and 240 
sub-networks. These network modules are interconnected and embedded within them are 241 
the signalling inputs that direct cell behaviour (Chen et al, 2017). Because of the hierarchical 242 
network organisation and the crosstalk between regulatory modules, failure to maintain 243 
components of just one module will essentially shutdown the entire developmental 244 
programme. This is precisely what we observe in the absence of Lsd1 function. Lsd1 245 
expression is activated in OEPs after specification, and its expression persists in otic cells as 246 
they commit to their fate. Therefore, by directly maintaining the expression of key players in 247 
the OEP module (Sox8, Pax2, Etv4 and Zbtb16) that precede its own expression, Lsd1 248 
becomes part of a sub-network that acts like a central hub for the entire ear cascade. 249 
Interestingly, these Lsd1 targets are dependent on FGF signalling for their initial expression, 250 
13 
 
and Lsd1 is known to regulate both Wnt and FGF signalling pathways (Chen et al, 2016; He 251 
et al, 2016; Huang et al, 2017; Huang et al, 2013; Lei et al, 2015; Takeuchi et al, 2015). 252 
In the zebrafish lateral line, Lsd1 is required to activate Etv4, Axin2 and Tcf7l2 to 253 
promote supporting cell proliferation upon hair cell damage (He et al, 2016), whereas it 254 
downregulates Etv2 to promote commitment of hematopoietic progenitor cells to their fate 255 
(Takeuchi et al, 2015). Furthermore, in cancer cells, Lsd1 promotes the Wnt pathway by 256 
repressing negative regulators of Wnt/β-Catenin signalling like APC, Prickle, Sfrp5 and Dkk1 257 
(Huang et al, 2017; Huang et al, 2013; Lei et al, 2015). In contrast, Lsd1 can also negatively 258 
regulate Wnt signalling by repressing Wnt pathway components such as Fzd1/2 to promote 259 
mesenchymal stem cell differentiation into brown adipocytes (Chen et al, 2016). In the ear, 260 
Wnt signalling is required for the transition of OEPs to committed otic cells (Freter et al, 261 
2008; Jayasena et al, 2008; Park & Saint-Jeannet, 2008). Thus, it is possible that 262 
maintenance of the OEP module by Lsd1 is necessary for OEPs to retain competence to 263 
respond to Wnt signalling and that Lsd1 directly or indirectly promotes the expression of Wnt 264 
pathway components.  265 
Virtually nothing is known about the upstream regulators of Lsd1, although in our 266 
NanoString data, the expression of Lsd1 itself is lost upon Lsd1-MO knockdown. As the 267 
expression of Sox8, Pax2, Etv4 and Zbtb16 in OEP cells precede Lsd1 expression, it is likely 268 
that one or more of these factors regulate Lsd1 expression. 269 
 270 
The Lsd1-cMyb coactivator complex prevents deactivation of OEP promoters 271 
Lsd1 is a demethylase found in both activator and repressor complexes. While the latter is 272 
well studied (Lin et al, 2010; Shi et al, 2005), its role as a coactivator is poorly defined. When 273 
Lsd1 is recruited by hormone nuclear receptors to their target promoters, its substrate 274 
specificity switches from H3K4me2 to H3K9me2 (Metzger et al, 2016; Metzger et al, 2005). 275 
In turn, demethylated H3K9 provides a substrate for histone acetyltransferases, with H3K9ac 276 
at promoter regions being a hallmark for actively transcribed genes. In addition, the 277 
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neuronal-specific isoform Lsd1+8a targets H3K9 for demethylation in the absence of nuclear 278 
receptors (Laurent et al, 2015). However, this isoform is only found in mammals, but is 279 
absent in other vertebrates like chick, fish and frog (Laurent et al, 2015; Zibetti et al, 2010). 280 
Our experiments reveal that Lsd1 can indeed switch substrate preference to act as a 281 
coactivator in the presence of cMyb. 282 
In the otic placode, cMyb cooperates with Sox8 and Etv4 to control the expression of 283 
the late otic marker Sox10: cMyb knockdown results in Sox10 downregulation and the loss 284 
of placode thickening (Betancur et al, 2011). This phenotype is remarkably similar to Lsd1 285 
knockdown. Here, we show that Lsd1 and cMyb physically interact and that Lsd1 recruitment 286 
to its target promoters depends on the presence of cMyb. This finding suggests that both are 287 
part of the same molecular machinery that controls otic lineage commitment. As Pax2 is 288 
expressed prior to Lsd1, we propose that Lsd1 can only function in OEP maintenance when 289 
both cMyb and Lsd1 are present. Pax2 is initiated by FGF and one study suggests that this 290 
pathway must be downregulated (Freter et al., 2012) for cells to commit to the otic lineage. 291 
This coincides with the onset of Lsd1 expression, and it is therefore possible that Lsd1 acts 292 
to maintain Pax2 when FGF signalling begins to decline. 293 
At promoter regions of OEP genes, Lsd1 prevents accumulation of the repressive mark 294 
H3K9me1/2 through its demethylase activity allowing H3K9ac accumulation. cMyb is likely to 295 
play a key role to facilitate this. Unlike the chromatin-interacting SANT domain, which 296 
facilitates histone deacetylation by HDACs (Boyer et al, 2004), the cMyb SANT domain 297 
binds DNA and cMyb recruits the histone acetyltransferase p300 via its transactivation 298 
domain (Mo et al, 2005). In contrast, high levels of H3K9 methylation are essential along the 299 
gene body of actively transcribed genes and this is facilitated by histone methyltransferases 300 
like Setdb1 or Ehmt2 (also known as G9a) (Layman & Zuo, 2014; Ooi & Wood, 2007). 301 
During adipogenesis Lsd1 opposes the activity of Setdb1 at target promoters to prevent 302 
premature differentiation (Musri et al., 2010). However, the precise mechanism of how this 303 
occurs and whether Lsd1 modifies Setdb1 itself or whether there is negative feedback 304 
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between the complexes remains elusive. We therefore suggest that the Lsd1-cMyb-p300 305 
coactivator complex at the promoter region of OEP genes is crucial to counteract HDAC and 306 
EHMT activities, and as a result prevents deactivation of OEP transcripts. 307 
In addition, Lsd1 may also be part of a repressor complex as HDACs and 308 
REST/coREST are present in OEPs, albeit being ubiquitously expressed in the embryo 309 
(Chen et al, 2017). In this context Lsd1 may be important to repress non-otic genes, which 310 
may in turn prevent ear development. We have previously shown that in the absence of 311 
additional signals, sensory progenitors in the PPR activate the lens programme through 312 
expression of the early marker Pax6 and late lens genes like L-maf and δ-crystallin. Lsd1 313 
knockdown leads to the upregulation of lens genes, although at very low levels, and it is 314 
therefore tempting to speculate that Lsd1 is part of the machinery that prevents the lens 315 
default fate (Bailey et al, 2006). However, the upregulation of these genes is not maintained, 316 
possibly due to inhibitory signals, and therefore the cells do not progress towards lens 317 
development. Together our findings suggest that the Lsd1-cMyb-p300 coactivator complex 318 
lies at the heart of a mechanism that maintains OEP identity, and that Lsd1 is a molecular 319 
cell fate switch that ensures the execution of the ear programme. 320 
 321 
Epigenetic regulation of cell maintenance and fate commitment in the embryo 322 
Much of our understanding of the epigenetic regulation of cell fate decisions centres around 323 
maintenance of embryonic, neural or hematopoietic stem cells (Adamo et al, 2011; Foster et 324 
al, 2010; Sun et al, 2010; Takeuchi et al, 2015; Thambyrajah et al, 2016), cancer cells 325 
(Huang et al, 2017; Lei et al, 2015) and progenitor cell differentiation in the fetal or postnatal 326 
retina (Popova et al, 2016), anterior pituitary (Wang et al, 2007) or nervous system (Ballas et 327 
al, 2005). In all these cases, Lsd1 acts as a corepressor to either maintain stem cell identity 328 
or allow differentiation towards a particular fate, mostly targeting H3K4me1 at enhancer or 329 
H3K4me2 at promoter regions. However, there is limited evidence of the crosstalk between 330 
genetic and epigenetic regulation of cell fate in the developing embryo. To our knowledge, 331 
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this is the first report that demonstrates a coactivator role for Lsd1 in cell fate maintenance. 332 
Our findings place Lsd1 within a gene regulatory network and show how a single epigenetic 333 
modifier maintains a network module that is in turn crucial to promote the ear programme. 334 
Many factors within this module are involved in other biological processes, cancer and/or 335 
mutated in human syndromes. Thus, from a therapeutic perspective, this study may provide 336 
insights into the mechanisms underlying the human syndromes caused by mutations in 337 
LSD1 (Chong et al, 2016; Tunovic et al, 2014) such as cleft palate, psychomotor retardation 338 
and distinct facial features (CPRF; OMIM # 616728) as well as overlapping features with 339 
Kabuki syndrome (OMIM # 300867).   340 
17 
 
Materials and Methods 341 
 342 
Chromatin immunoprecipitation (ChIP) 343 
Otic tissue collected in nuclear extraction buffer (10mM Tris-HCL pH7.5, 3mM CaCl2, 250mM 344 
Sucrose, 0.5% NP-40, 0.25% TritonX-100, supplemented with 1mM DTT and protease 345 
inhibitors, PI) was homogenised using a dounce homogeniser on ice, cross-linked in 0.9% 346 
formaldehyde, quenched with 125mM glycine. Nuclei were pelleted, washed in PBS (with 347 
DTT/PI) and lysed in SDS lysis buffer (50mM Tris-HCl pH8, 1% SDS, 10mM EDTA pH8, PI) 348 
on ice for 1hr to release cross-linked chromatin. The chromatin was then sonicated using 349 
SorvicsVibra Cell and probe CV18 on ice in ChIP buffer without DTT (16.7mM Tris-HCl pH8, 350 
0.% SDS, 1.2mM EDTA pH8, 167mM NaCl) to obtain DNA fragments of 0.2-1kb. 351 
Fragmented chromatin was diluted in ChIP buffer with 1mM DTT and PI. Protein A magnetic 352 
beads (Invitrogen 10002D) were blocked in 0.5% BSA/PBS, incubated with 5µg of antibody 353 
at 4°C O/N on a rotator, collected using a magnetic stand (Invitrogen 12321D). 354 
Immunoprecipitation was performed by resuspending antibody-beads in fragmented 355 
chromatin at 4°C O/N on a rotator, then repeatedly washed in RIPA buffer (50mM HEPES-356 
KOH pH8, 500mM LiCl, 1mM EDTA pH8, 1% NP-40, 0.7% sodium deoxycholate, PI) 357 
followed by TE/50mM NaCl wash. Elution was performed at 65°C for 15min with elution 358 
buffer (50mM Tris-HCl pH8, 10mM EDTA pH8, 1% SDS) and reverse cross-linked at 65°C 359 
O/N together with input, then treated with RNAse A for 1hr at 37°C followed by 0.2µg/ml 360 
proteinase K at 55°C for 1hr. DNA was recovered by phenol-chloroform extraction and 361 
ethanol precipitation. RT-qPCR was performed using SYBR green and AriaMx Real-Time 362 
PCR System (Agilent Technologies). Antibodies were from Abcam: Lsd1 (ab17721), H3K9ac 363 
(ab4441), H3K9me2 (ab1220). 364 
 365 
Co-immunoprecipitation (Co-IP)  366 
For immunoprecipitation assays, nuclear cell extracts from neuroblastoma cells were 367 
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precleared in 0.5% BSA for 1hr on ice then with protein A magnetic beads for 30min at 4°C 368 
to reduce non-specific binding and background. Precleared lysates were separated from the 369 
beads and incubated with 5µg of antibody (anti-Lsd1, Abcam ab17721) in Co-IP buffer 370 
(20mM Tris-HCl pH7.5, 100mM NaCl, 0.2% TritonX-100, 0.2% NP-40, 2mM β-371 
mercaptoethanol, 0.2% sodium deoxycholate, 1mM DTT, PI) at 4°C O/N, then with beads for 372 
4hrs at 4°C followed by repeated washes in wash buffer (20mM HEPES pH7.5, 1.25mM 373 
MgCl2, 0.1mM EDTA pH8, 10% glycerol, 0.2% NP-40, 100mM KCl, 1mM DTT, PI). Beads 374 
were collected, resuspended in 2x SDS loading buffer, boiled for 5min at 95°C and run on 375 
SDS-PAGE gel for WB. 376 
 377 
Western blot (WB) 378 
Protein lysates from neuroblastoma cells were separated by SDS-PAGE and transferred 379 
onto PVDF membranes using a Bio-Rad Trans-blot Turbo transfer system. After blocking, the 380 
membranes were incubated in primary antibody (anti-cMyb, Abcam ab45150 or anti-Lsd1) 381 
overnight at 4°C followed by PBST washes and incubation with HRP-conjugated secondary 382 
antibody for 2 hours. Signals were visualised using Bio-Rad Clarity Western ECL Substrate 383 
and Bio-Rad ChemiDoc Touch imaging system. 384 
 385 
ChIP-qPCR data and statistical analysis 386 
Input Ct values were adjusted for the dilution factor and ∆Ct calculated by normalising Ct 387 
values to the adjusted input: ∆Ct=Ct(input)-Ct(IP). The % input was calculated as % Input = 388 
100x2e-∆Ct. Fold enrichment was calculated using % input of IP/IgG: (∆Ct(IP)/∆Ct(IgG). Error 389 
bars represent the standard error. Unless otherwise indicated, differences between 390 
experimental groups were compared using an unpaired two-tailed Student’s t-test and a P-391 
value of ≤0.05 was considered statistically significant. 392 
 393 
Fluorescence quantification 394 
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ImageJ was used to measure the integrated density (fluorescence intensity) in the region of 395 
interest for both electroporated and drug treated samples. For electroporated cells, the mean 396 
fluorescence intensity of targeted cells/Hoechst was compared to non-targeted 397 
cells/Hoechst, whereas for drug-treated vs untreated samples, the entire placode/Hoechst 398 
was measured. To correct for different exposure levels between channels and individual 399 
samples, the integrated density from the mean of 3 background areas was also calculated. 400 
The formula used to estimate the corrected total cell fluorescence (CTCF) was as follows: 401 
Integrated density – (Area of selection x Mean fluorescence of background reading). 402 
Statistical significance was estimated using unpaired t-test. 403 
 404 
Motif enrichment analysis 405 
Transcription factor binding motifs were predicted using JASPAR database 406 
(http://jaspar.genereg.net/cgi-bin/jaspar_db.pl) and P-Match program from Transfac 407 
database (http://www.gene-regulation.com/pub/programs.html). A profile matrix was 408 
generated to run a pattern matching scan using RSAT (http://rsat.sb-roscoff.fr/) on the 409 
promoters for enrichment against the background (chicken genome). 410 
 411 
Pharmacological inhibition 412 
Dissected OEP tissues were cultured in collagen with trans-2-phenylcyclopropylamine 413 
(tranylcyclopromine, TCP, at 25µm working concentration prepared in sterile water) in culture 414 
medium. Explants were incubated with drug (or no drug control) for 30 minutes at room 415 
temperature before culturing for either 4.5 or 9 hours. For sectioning and 416 
immunofluorescence, the whole embryo or head was cultured in the presence or absence of 417 
drug for 12 hours on polycarbonate membranes (Corning, 3422). 418 
 419 
In ovo electroporation and tissue dissection 420 
Fertilised hen’s egg (Winter Farm, Hertfordshire) were incubated in a humidified incubator at 421 
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38°C to reach ss5-6. Eggs were windowed and embryos visualised with India ink (Pelikan; 422 
diluted 1:5 in Tyrodes saline). The positive (platinum) electrode was placed under the 423 
embryo at hindbrain (r4) level, DNA/morpholino injected below the vitelline membrane, 424 
negative (tungsten) electrode placed on top and current applied using an Intracel 425 
electroporator (settings: 5 volts, 5 pulses, 50ms, 10ms duration). Tyrodes saline 426 
supplemented with penicillin streptomycin was applied to the embryo, egg resealed with tape 427 
and incubated to the appropriate stage. Placodes were dissected as described previously 428 
(Anwar et al, 2017; Chen et al, 2017). 429 
 430 
In situ hybridisation and immunofluorescence 431 
Embryos were fixed in 4% paraformaldehyde (PFA) overnight at 4°C and in situ hybridisation 432 
performed using DIG-labelled riboprobes. For antibody staining, embryos were embedded in 433 
paraffin wax or gelatine and sectioned to 8µm. Primary antibodies were: anti-H3K9ac 434 
(Abcam ab4441) 1:100; anti-H3K9me2 (Abcam ab1220) 1:100; anti-FITC 488 (Thermo 435 
Scientific 4-4-20) 1:500; anti-mCherry (Abcam ab167453) 1:500; anti-cleaved caspase 3 436 
(Cell Signalling 9964B) 1:300 and anti-Lsd1 (Abcam ab17721) 1:300. Secondary antibodies 437 
were: goat anti-rabbit or anti-mouse Alexa Fluor 568 (1:1000, Invitrogen) and Alexa Fluor 438 
635 (1:500, Invitrogen). 439 
 440 
Morpholinos and DNA constructs 441 
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Fluoresceinated morpholino antisense oligonucleotides were obtained from Gene Tools 442 
(USA) with standard Ctrl-MO (5’ – CCTCTTACCTCAGTTACAATTTATA – 3’) from 443 
manufacturer and cMyb-MO (5’ – ATGGCCGCGAGCTCCGCGTGCAGAT – 3’) published in 444 
Betancur et al., 2011. Both Lsd1 morpholinos were splice morpholinos. Lsd1-MO 1: (5’ – 445 
TTTGTGAAACTCACCAAGTCCTGTT – 3’) deletes exon 8 (enzymatic domain). Lsd1-MO 2 446 
(5’ – ATCACTGGACAAAATCTGACCTTGT – 3’) deletes exon 11 (substrate binding domain). 447 
All morpholinos were used at 1mM final concentration. Lsd1-RFP expression constructs 448 
were generated by subcloning the human Lsd1 (gift from Prof. Yang Shi) open reading frame 449 
into pCAB.IRES.RFP vector. 450 
 451 
Quantitative RT-PCR and NanoString nCounter analysis 452 
Preparation of tissue for qPCR and NanoString analysis were conducted as previously 453 
described (Anwar et al, 2017; Chen et al, 2017).  454 
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Figure Legends 656 
 657 
Fig.1. Lsd1 is expressed in progenitor cells after their specification. At ss5, Lsd1 is 658 
expressed in the neural tube (nt) and mesoderm (m) but not in otic-epibranchial progenitors 659 
(A, a; arrowhead). At ss8 (B, b) and ss13 (C, c), Lsd1 is expressed in the otic placode and 660 
lateral ectoderm (arrowhead). The expression of Lsd1 in OEPs begins at ss8-9 after OEP 661 
specification indicated by Pax2 expression (D). Sdha was used as a housekeeping gene to 662 
determine the qPCR mRNA expression levels. 663 
 664 
Fig.2. Lsd1 is necessary for otic placode and vesicle formation. (A-b’) left and right side 665 
of the same embryo. (A) normal otic vesicle. (a) higher magnification of the area boxed in A. 666 
(a’) cross section of region indicated by line in A. (B) Lsd1-MO electroporated cells do not 667 
form an otic vesicle – only non-targeted cells (inset; yellow arrow) do. (b) higher 668 
magnification of the area boxed in B. (b’) cross section of region indicated by line in B. 669 
Asterisk: normal otic vesicle on the left side that can also be seen from the right side. The 670 
expression of OEP markers (C’-E’; c-e) is abolished on the side electroporated with Lsd1-671 
MO (C-E; green). Black line: sectioned regions shown in c-e. Dashed boxes: in C-E’ = OEP 672 
region on the electroporated side; in c = regions shown in insets at higher magnification. 673 
 674 
Fig.3. Differentially regulated genes following Lsd1-MO knockdown. (A, B) Volcano plot 675 
representing changes in gene expression by NanoString analysis following Lsd1 knockdown 676 
at late OEP (ss8-9) and lineage-committed placodal (ss11-12) stages. Genes affected at 677 
ss8-9 are potential immediate targets of Lsd1. (C) Validation of selected genes by qPCR 678 
following pharmacological inhibition of Lsd1 with TCP. Experiments were conducted in 679 
triplicates and Sdha was used for normalisation. 680 
 681 
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Fig.4. Lsd1 occupies the promoters of target genes to remove H3K9me2. (A) Lsd1 682 
ChIP-qPCR on promoters of genes that are downregulated after Lsd1 inhibition. Bar diagram 683 
shows relative enrichment of Lsd1 binding compared to IgG controls. Lsd1 binds to the 684 
promoters of OEP, but not PPR genes. (B) To maintain active transcription, Lsd1 prevents 685 
accumulation of methyl groups on H3K9 thus allowing it to remain acetylated. In the absence 686 
of Lsd1, H3K9 methylation accumulates as H3K9ac is lost and the promoter is 687 
transcriptionally silenced. (C, D) ChIP for histone marks shows an increase of H3K9me2 at 688 
the target promoters following Lsd1 inhibition (C) and simultaneous loss of H3K9ac (D). 689 
 690 
Fig.5. Lsd1 interacts with cMyb which recruits it to target promoters. (A) Motif 691 
enrichment analysis shows that Myb binding site is present in the promoters of all four OEP 692 
genes; cMyb is expressed at the appropriate time in the OEPs. (B) Neuroblastoma cell lines 693 
express Lsd1 and cMyb. (B’, B’’) Immunoprecipitation with Lsd1 antibody followed by cMyb 694 
western blot reveals Lsd1-cMyb interaction. (C) Lsd1 promoter occupancy is lost following 695 
MO-mediated knock-down of cMyb. 696 
 697 
Fig.6. Model for an Lsd1-cMyb coactivator complex in progenitor cell maintenance. (A) 698 
OEPs arise from sensory progenitors (PPR) identified by a set of genes. FGF activates OEP 699 
genes in the PPR; cMyb is not induced by FGF but becomes expressed at the same time. In 700 
a transitory state, OEPs upregulate Lsd1 and maintain their identity until they respond to 701 
new signals and commit to a particular lineage by activating additional fate-specific genes. 702 
(B) cMyb recruits Lsd1 to active OEP promoters already decorated with H3K4 methylation 703 
and H3K9ac. To maintain their expression, Lsd1 prevents H3K9 methylation at the promoter, 704 
thereby allowing H3K9 to remain acetylated, and restricts H3K9me2 to the gene body. (C) 705 
Inhibition of Lsd1 (1) results in the loss of H3K9ac and gain of H3K9me2 at the active 706 
promoters, which are rapidly silenced and OEP gene expression is lost. Loss of cMyb (2) 707 
prevents the recruitment of Lsd1 to the promoters leading to the same outcome as Lsd1 708 
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inhibition. 709 






